MedPath

Phototherapy with topical minoxidil in vitiligo:A Randomised control trial

Phase 3
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2023/10/059079
Lead Sponsor
Sejal Bajoria
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinically diagnosed cases of Vitiligo

Exclusion Criteria

1.Pregnant and Lactating Females.

2.Patients with immunocompromised state.

3.Females with Vitiligo patches on Face

4.Patients with photosensitive disorders.

5.Patients who do not want increased hair growth

over the lesions

6.Patients who are allergic to minoxidil or are

unable to tolerate minoxidil.

7.Patients with depigmented hair on the lesions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Repigmentation of test patchTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath